Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Carcinoma × trifluridine tipiracil drug combination × Clear all

Sponsor

Conditions

Colorectal Neoplasms 11 Neoplasm Metastasis 5 Stomach Neoplasms 2 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Gallbladder Neoplasms 2 Pancreatic Neoplasms 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Gastric Adenocarcinoma 1 Digestive System Diseases 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma 1 Bile Duct Neoplasms 1 Advanced or Metastatic Solid Tumors 1 Advanced Solid Tumors 1 Adenocarcinoma 1

Interventions

Cisplatin 4 pembrolizumab 2 Nivolumab 2 Fluorouracil 2 Carboplatin 2 toripalimab 1 spartalizumab 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 camrelizumab 1 Vorinostat 1 Range of Motion, Articular 1 Radiotherapy 1 Radiosurgery 1 Protons 1 Platinum 1 Methylprednisolone 1 Medicare Part B 1 Laryngoscopes 1 Gemcitabine 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1 Azacitidine 1 Adrenal Cortex Hormones 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡